Furthermore, we explore the independent prognostic value of liquid biopsy markers and PET imaging metrics, such as PSMA-derived tumor volume (PSMA-TV), metabolic tumor volume (MTV), and standardized uptake value (SUVmax), in predicting overall survival (OS) and progression-free survival (PFS). The gene discussed is FOLH1; the disease is neoplasm.